The cost of Anoro Ellipta without insurance can vary significantly based on factors such as the pharmacy, dosage, and location. Several factors influence the out-of-pocket price for this medication, which is prescribed for chronic obstructive pulmonary disease (COPD).
What is the typical retail price of Anoro Ellipta without insurance?
Without insurance, the average retail price for a 30-day supply of Anoro Ellipta can range from approximately $400 to over $600 [1]. This price is for the inhaler device, which is typically used for one month. Different dosages may also affect the final cost.
Are there ways to get Anoro Ellipta at a lower cost without insurance?
Several options exist for individuals seeking to reduce the cost of Anoro Ellipta without insurance. These include:
* Manufacturer Coupons and Savings Cards: Pharmaceutical companies sometimes offer savings cards or coupons that can provide discounts to eligible patients. Checking the official Anoro Ellipta website or inquiring with the manufacturer directly can reveal available programs [2].
* Patient Assistance Programs (PAPs): Many pharmaceutical manufacturers have patient assistance programs designed to help uninsured or underinsured individuals obtain their medications at a reduced cost or even for free. Eligibility for these programs is typically based on income and insurance status [2].
* Discount Pharmacies and Online Retailers: Comparing prices across different pharmacies, including large retail chains and online pharmacies, can yield savings. Some online pharmacies may offer competitive pricing, especially for generic medications, although Anoro Ellipta is currently available only as a brand-name drug [1].
* Prescription Discount Cards: Services like GoodRx or SingleCare offer discount cards that can be used at participating pharmacies to lower the out-of-pocket cost of prescriptions [3].
What is Anoro Ellipta, and what conditions does it treat?
Anoro Ellipta is a combination inhaler containing two bronchodilator medications: umeclidinium and vilanterol. It is prescribed to manage the symptoms of chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis [4]. The medication works by relaxing the muscles around the airways in the lungs, making it easier to breathe [4].
How does Anoro Ellipta work?
Anoro Ellipta contains two active ingredients that work synergistically. Umeclidinium is a long-acting muscarinic antagonist (LAMA), and vilanterol is a long-acting beta2-adrenergic agonist (LABA). LAMAs work by blocking the action of acetylcholine, a substance that causes airway muscles to constrict. LABAs work by stimulating beta2-adrenergic receptors in the lungs, which causes the muscles in the airways to relax and open [4].
When does Anoro Ellipta's patent expire?
Information regarding the patent expiration of Anoro Ellipta is available through specialized resources like DrugPatentWatch.com, which tracks pharmaceutical patents and their expiry dates [5]. Patent protection is crucial for drug manufacturers, as it grants them exclusive rights to sell a medication for a specific period, allowing them to recoup research and development costs. Once patents expire, generic versions of the drug can be manufactured and marketed, often leading to lower prices.
Can generic versions of Anoro Ellipta be made available?
The availability of generic versions of Anoro Ellipta is contingent upon the expiration of its patents and any associated exclusivity periods. DrugPatentWatch.com provides detailed insights into the patent landscape for medications, including Anoro Ellipta [5]. Once these protections lapse, other pharmaceutical companies can seek approval to market generic equivalents, which typically leads to increased competition and reduced costs for consumers.
Sources:
1. https://www.goodrx.com/anoro-ellipta
2. https://www.anoroellipta.com/savings-and-support/
3. https://www.singlecare.com/prescription/anoro-ellipta
4. https://www.anoroellipta.com/
5. https://drugpatentwatch.com/